Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

Oral penicillin may be a safer option for people with high-risk rheumatic heart disease

Study evaluates acute and long-term adverse events following immunization with COVID-19 Moderna vaccine

Study evaluates acute and long-term adverse events following immunization with COVID-19 Moderna vaccine

International approaches to tackling food fraud

International approaches to tackling food fraud

Mathematical modeling the vaccination of children against SARS-CoV-2

Mathematical modeling the vaccination of children against SARS-CoV-2

Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform

Clear, specific product labeling for sesame is crucial to prevent anaphylaxis

Clear, specific product labeling for sesame is crucial to prevent anaphylaxis

Temporary suspension of 15-minute observation period after vaccination to accelerate booster program

Temporary suspension of 15-minute observation period after vaccination to accelerate booster program

Can you take the COVID-19 and Influenza vaccines on the same day?

Can you take the COVID-19 and Influenza vaccines on the same day?

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

Maternal pre-pregnancy BMI linked to pediatric allergic disease development

Maternal pre-pregnancy BMI linked to pediatric allergic disease development

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Researchers find no serious health effects linked to mRNA COVID-19 vaccines

Researchers find no serious health effects linked to mRNA COVID-19 vaccines

FDA approves an intravenous medication to treat patients with Pompe disease

FDA approves an intravenous medication to treat patients with Pompe disease

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Study reveals safety of second mRNA COVID-19 vaccine dose after allergic reactions to first dose

Study reveals safety of second mRNA COVID-19 vaccine dose after allergic reactions to first dose

mRNA COVID-19 vaccines may increase patients' concerns about side effects

mRNA COVID-19 vaccines may increase patients' concerns about side effects

Updated ACR position statement on patient safety and site of service for biologics released

Updated ACR position statement on patient safety and site of service for biologics released